Literature DB >> 3347345

The natural history of motoneuron loss in amyotrophic lateral sclerosis.

T L Munsat1, P L Andres, L Finison, T Conlon, L Thibodeau.   

Abstract

Using a quantitative, reliable, sensitive and valid measurement technique, we analyzed the rate and pattern of motor deterioration in 50 strictly defined ALS patients for up to 67 months. We observed that the rate of motoneuron loss was linear and symmetric. Bulbar function deteriorated more slowly than respiratory, arm, and leg function. The loss of leg strength was slower than in the arm. No correlation was observed between age at onset and rate of deterioration, or with different regions of onset. Arm strength changed more slowly in women, but other functions showed no male-female differences. These data should prove useful in the design of clinical trials and in generating testable hypotheses of the etiology of this disease.

Entities:  

Mesh:

Year:  1988        PMID: 3347345     DOI: 10.1212/wnl.38.3.409

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  19 in total

Review 1.  Treatment of amyotrophic lateral sclerosis.

Authors:  A Eisen; M Weber
Journal:  Drugs Aging       Date:  1999-03       Impact factor: 3.923

2.  EMG evaluation of motor neuron sprouting in amyotrophic lateral sclerosis.

Authors:  P Pinelli; F Pisano; F Ceriani; G Miscio
Journal:  Ital J Neurol Sci       Date:  1991-08

Review 3.  Measures and markers in amyotrophic lateral sclerosis.

Authors:  Merit Cudkowicz; Muhammad Qureshi; Jeremy Shefner
Journal:  NeuroRx       Date:  2004-04

Review 4.  ALS motor phenotype heterogeneity, focality, and spread: deconstructing motor neuron degeneration.

Authors:  John M Ravits; Albert R La Spada
Journal:  Neurology       Date:  2009-09-08       Impact factor: 9.910

Review 5.  Strength Testing in Motor Neuron Diseases.

Authors:  Jeremy M Shefner
Journal:  Neurotherapeutics       Date:  2017-01       Impact factor: 7.620

6.  Facioscapulohumeral muscular dystrophy: a prospective study of weakness and functional impairment.

Authors:  Joerg-Patrick Stübgen; Annette Stipp
Journal:  J Neurol       Date:  2010-03-30       Impact factor: 4.849

7.  Continuous response variable trial design in motor neuron disease: long term treatment with a TRH analogue (RX77368).

Authors:  A Goonetilleke; R J Guiloff
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-02       Impact factor: 10.154

8.  An open-randomized clinical trial of selegiline in amyotrophic lateral sclerosis.

Authors:  L Mazzini; D Testa; C Balzarini; G Mora
Journal:  J Neurol       Date:  1994-02       Impact factor: 4.849

Review 9.  Physical activity and neuroprotection in amyotrophic lateral sclerosis.

Authors:  Mary E McCrate; Brian K Kaspar
Journal:  Neuromolecular Med       Date:  2008-02-20       Impact factor: 3.843

10.  Selective Motor Neuron Resistance and Recovery in a New Inducible Mouse Model of TDP-43 Proteinopathy.

Authors:  Krista J Spiller; Claudia J Cheung; Clark R Restrepo; Linda K Kwong; Anna M Stieber; John Q Trojanowski; Virginia M-Y Lee
Journal:  J Neurosci       Date:  2016-07-20       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.